|
KR20110009638A
|
|
A feed additive containig novel lactobacillus spp. complex
|
|
KR20110009626A
|
|
A feed additive containing novel lactobacillus reuteri
|
|
KR20110044427A
|
|
Differential identification of salmonella enterica serovar gallinarum biovar gallinarum, pullorum and biovar gallinarum live vaccine strains
|
|
KR20110038380A
|
|
Rt-pcr for differentiation of seven serotypes of foot-and-mouth disease virus
|
|
KR20110034154A
|
|
Construction of a genetically engineered glycoprotein of vesicular stomatitis virus serotype new jersey and its application
|
|
KR20110031012A
|
|
Diagnostic method for the detection of antibodies to foot-and-mouth disease virus type asia 1
|
|
KR20110017706A
|
|
Primers and its application in multiplex pcr to identify rinderpest, peste-des-petits-ruminants virus, bluetongue virus and rift valley fever
|
|
KR20110009976A
|
|
Monoclonal antibody for discriminating and detecting abnormal prion causing chronic wasting disease
|
|
KR20110009967A
|
|
Monoclonal antibody for discriminating and detecting abnormal prion causing bovine spongiform encephalopathy
|
|
KR20110009516A
|
|
A compound for feed additive comprising novel lactobacillus salivarius g1-1
|
|
KR20100136191A
|
|
Antigen for high concentrated hemagglutination of porcine japanese encephalitis virus and method therefor
|
|
KR20100128739A
|
|
Monoclonal antibody enhanced the specificity and affinity of binding to aflatoxin b1 and the kit for detecting aflatoxin b1 comprising thereof
|
|
KR20100127407A
|
|
Monoclonal antibody enhanced the specificity and affinity of binding to zearalenone and the kit for detecting zearalenone comprising the same
|
|
KR20100121823A
|
|
Recombinant viral vector using bovine enterovirus and the method for producing thereof
|
|
KR20100121288A
|
|
Genetic recombinant classical swine fever vaccine flc-lom-berns virus and preparing method thereof
|
|
KR20100121289A
|
|
Genetic recombinant classical swine fever vaccine flc-lom virus and preparing method thereof
|
|
KR20100114606A
|
|
Composition for prevention or treatment of diseases caused by staphylococcus aureus
|
|
KR20100110434A
|
|
Method for attenuation of pathogen using neutrophils
|
|
KR20100105974A
|
|
Rift valley fever competition elisa using monoclonal antibodies against recombinant n protein
|
